{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T14:28:26Z","timestamp":1780756106958,"version":"3.54.1"},"reference-count":9,"publisher":"The Japanese Society for Medical Mycology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Mycology Journal"],"published-print":{"date-parts":[[2023,10,31]]},"DOI":"10.3314\/mmj.23-00005","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T22:15:36Z","timestamp":1701296136000},"page":"103-105","source":"Crossref","is-referenced-by-count":5,"title":["&lt;i&gt;In vitro&lt;\/i&gt; Azole Susceptibility Testing of Japanese Isolates of Itraconazole-Resistant Dermatophytes"],"prefix":"10.3314","volume":"64","author":[{"given":"Honoka","family":"Nojo","sequence":"first","affiliation":[{"name":"Teikyo University Institute of Medical Mycology (TIMM)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichiro","family":"Hiruma","sequence":"additional","affiliation":[{"name":"Teikyo University Institute of Medical Mycology (TIMM)"},{"name":"Department of Dermatology, Tokyo Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Noguchi Dermatology Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataro","family":"Hiruma","sequence":"additional","affiliation":[{"name":"Ochanomizu Institute for Medical Mycology and Allergology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoshi","family":"Harada","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Tokyo Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Makimura","sequence":"additional","affiliation":[{"name":"Teikyo University Institute of Medical Mycology (TIMM)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Kano","sequence":"additional","affiliation":[{"name":"Teikyo University Institute of Medical Mycology (TIMM)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1842","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Havlickova B, Czaika VA, Friedrich M: Epidemiological trends in skin mycoses worldwide. Mycoses 51 (Suppl 4): 2&ndash;15, 2008.","DOI":"10.1111\/j.1439-0507.2008.01606.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Langfeldt A, Gold JAW, Chiller T: Emerging fungal infections: from the fields to the clinic, resistant <i>Aspergillus fumigatus<\/i> and dermatophyte species: a one health perspective on an urgent public health problem. Curr Clin Microbiol Rep 9: 46&ndash;51, 2022.","DOI":"10.1007\/s40588-022-00181-3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Saunte DML, Pereiro-Ferreir\u00f3s M, Rodr\u00edguez-Cerdeira C, et al: Emerging antifungal treatment failure of dermatophytosis in Europe: take care or it may become endemic. J Eur Acad Dermatol Venereol 35: 1582&ndash;1586, 2021.","DOI":"10.1111\/jdv.17241"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Sacheli R, Hayette MP: Antifungal\u00a0resistance\u00a0in\u00a0dermatophytes: genetic considerations, clinical presentations and\u00a0alternative\u00a0therapies. J Fungi (Basel) 7: 983, 2021.","DOI":"10.3390\/jof7110983"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Hiruma J, Noguchi H, Shimizu T, Hiruma M, Harada K, Kano R: Epidemiological study of antifungal-resistant dermatophytes isolated from Japanese patients. J Dermatol 50: 1068&ndash;1071, 2023.","DOI":"10.1111\/1346-8138.16780"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Itoi S, Kano R, Hasegawa A, Kamata H: <i>In vitro<\/i> activities of antifungal agents against clinical isolates of dermatophytes from animals. J Vet Med Sci 74: 1067&ndash;1069, 2012.","DOI":"10.1292\/jvms.12-0057"},{"key":"7","unstructured":"7) CLSI: Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A2. Clinical Laboratory Standards Institute, Philadelphia, 2002."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Carmo PHF, Costa MC, Leoc\u00e1dio VAT, Gouveia-Eufr\u00e1sio L, Em\u00eddio ECP, Pimentel SP, Paix\u00e3o TA, Peres NTA, Santos DA: Exposure to itraconazole influences the susceptibility to antifungals, physiology, and virulence of <i>Trichophyton interdigitale<\/i>. Med Mycol 60: myac088, 2022.","DOI":"10.1093\/mmy\/myac088"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Kano R, Kimura U, Noguchi H, Hiruma M: Clinical isolate of a multi-antifungal-resistant <i>Trichophyton rubrum<\/i>. Antimicrob Agents Chemother 66: e0239321, 2022.","DOI":"10.1128\/aac.02393-21"}],"container-title":["Medical Mycology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mmj\/64\/4\/64_103\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T05:09:37Z","timestamp":1715576977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mmj\/64\/4\/64_103\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.3314\/mmj.23-00005","relation":{},"ISSN":["2185-6486","2186-165X"],"issn-type":[{"value":"2185-6486","type":"print"},{"value":"2186-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,31]]}}}